Zobrazeno 1 - 10 of 15 pro vyhledávání: '"Seong H, Jang"'
2
Variations in pharmacokinetic-pharmacodynamic target values across MICs and their potential impact on determination of susceptibility test interpretive criteria
Autor: Seong H Jang, Kellie S. Reynolds, Abhay Joshi, Ursula Waack
Publikováno v: Journal of Antimicrobial Chemotherapy. 76:2884-2889
Background An antibacterial drug’s susceptibility test interpretive criteria (STIC) are determined by integrating clinical, microbiological and pharmacokinetic-pharmacodynamic (PK-PD) data. PTA analysis plays a pivotal or supportive role in STIC de
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c478a50bdaff7985489793b6f3dac5c4
https://doi.org/10.1093/jac/dkab282
Zobrazit plný text záznamu
3
US Food and Drug Administration (FDA): Benefit-Risk Considerations for Cefiderocol (Fetroja®)
Autor: Kalavati Suvarna, Daniel B. Rubin, Seong H. Jang, Sumathi Nambiar, John Farley, Edward A. Weinstein, Karen Higgins, Dmitri Iarikov, Xiaohui Wei, Shabnam Naseer, Avery Goodwin
Publikováno v: Clinical Infectious Diseases. 72:e1103-e1111
In November 2019, the Food and Drug Administration (FDA) approved cefiderocol for the treatment of complicated urinary tract infections (cUTI) including pyelonephritis caused by susceptible gram-negative bacteria in adults with limited to no alternat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dd9cce7b14affc891f3241c37d20ddd2
https://doi.org/10.1093/cid/ciaa1799
Zobrazit plný text záznamu
4
Evaluation of Hemodialysis Effect on Pharmacokinetics of Meropenem/Vaborbactam in End‐Stage Renal Disease Patients Using Modeling and Simulation
Autor: Kellie S. Reynolds, Yaning Wang, Jeffry Florian, Seong H. Jang, Yichao Yu, Xiaohui Wei, Luning Zhuang
Publikováno v: The Journal of Clinical Pharmacology. 60:1011-1021
The objectives of this study were to evaluate the effect of hemodialysis (HD) on the pharmacokinetics (PK) of meropenem/vaborbactam, an approved beta-lactam/beta-lactamase inhibitor combination, and provide the rationale for the recommended timing of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c698bccdb06faca7fe3d7338617d965
https://doi.org/10.1002/jcph.1595
Zobrazit plný text záznamu
5
Application of Population Pharmacokinetic Modeling, Exposure-Response Analysis, and Classification and Regression Tree Analysis to Support Dosage Regimen and Therapeutic Drug Monitoring of Plazomicin in Complicated Urinary Tract Infection Patients with Renal Impairment
Autor: Luning Zhuang, Kunyi Wu, Seong H. Jang, Kellie S. Reynolds, Shrimant Mishra, Dmitri Iarikov
Publikováno v: Antimicrob Agents Chemother
In 2018, the FDA approved plazomicin for the treatment of complicated urinary tract infections (cUTI) including pyelonephritis in adult patients with limited or no alternative treatment options. The objective of this article is to provide the scienti
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc2d07787ab51cb43b6e8aae9fc43f46
https://europepmc.org/articles/PMC9017347/
Zobrazit plný text záznamu
7
Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma
Autor: P M Colangelo, Seong H. Jang, Jogarao V. S. Gobburu
Publikováno v: Clinical Pharmacology & Therapeutics. 88:115-119
The purpose of this article is to report the exposure-response (E-R) relationship of posaconazole oral suspension (POS) for prophylaxis against invasive fungal infections (IFIs), on the basis of the US Food and Drug Administration (FDA) clinical phar
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7cd8a010e8668da396a971ca688738b
https://doi.org/10.1038/clpt.2010.64
Zobrazit plný text záznamu
8
Therapeutic drug monitoring: A patient management tool for precision medicine
Autor: J.A. Lazor, Z.G. Yan, Seong H. Jang
Publikováno v: Clinical pharmacology and therapeutics. 99(2)
The precision medicine initiative is designed to better understand the causes of disease, to develop target therapies, and to identify patients that would benefit from treatment. Prescribing the right dose, which is not always the same to all patient
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14421a22043b578aad5602641062d37e
https://pubmed.ncbi.nlm.nih.gov/26565378
Zobrazit plný text záznamu
9
Pharmacokinetics of ciprofloxacin after intravenous administration of ciprofloxacin-TOF in rabbits
Autor: Lee Hj, Sun H. Lee, Woo H. Yoon, Eun J. Yoon, Seong H. Jang, Jeong M. Park, Kyung E. Choi, Myung Gyoon Lee
Publikováno v: International Journal of Pharmaceutics. 102:249-255
The pharmacokinetic parameters and tissue distribution of ciprofloxacin were compared after intravenous (i.v.) administration of ciprofloxacin-HCl or ciprofloxacin-TOF salts, 30 mg kg −1 as free ciprofloxacin to rabbits. The pharmacokinetic paramet
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fa73da7c3938e3b519124ff4f45f997d
https://doi.org/10.1016/0378-5173(94)90062-0
Zobrazit plný text záznamu
10
Pharmacokinetics of a 22 kDa variant of unlabelled monomeric human growth hormone in rabbits
Autor: Seong H. Jang, Kye S. Han, In Soo Kim, Myung Gull Lee, Kyeong-Hoon Jeong, Woo Hyun Yoon, Sun Hwa Lee
Publikováno v: International Journal of Pharmaceutics. 90:81-86
The pharmacokinetic parameters of MHGH22K, such as the mean values of t 1 2 (9.30, 16.8, 22.2 vs 25.8 min), MRT (11.6, 21.7, 26.7 vs 37.9 min) and Vss (166, 218, 342 vs 556 ml kg−1) tended to increase with increasing doses after i.v. administration
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d1ac104bc467f6df6b98c04d418ab11f
https://doi.org/10.1016/0378-5173(93)90298-t
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje